249 devices · GMDN 30519
Cannabinoid/cannabinoid metabolite rapid tests are in-vitro diagnostic kits designed to quickly detect the presence of cannabinoids or their metabolites in clinical samples. These tests use immunochromatographic technology (lateral flow) to provide results within minutes, often at the point of care or in lab settings, helping clinicians assess recent drug exposure or compliance in patients.
These devices are typically regulated as in-vitro diagnostics and may require compliance with testing standards for accuracy, reliability, and performance. They are supplied as kits containing reagents and instructions for use, often intended for professional use in clinical or pre-employment screening scenarios, rather than self-testing.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.